Keywords: gsk/ligand, promacta, get, fda, priority, review, uk

GSK/Ligand's Promacta to get FDA priority review

Article | 10 March 2008

Print This

UK drug major GlaxoSmithKline says that the US Food and Drug Administration has granted a priority review for Promacta (eltrombopag) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in